Nuzenio

To Acquire Forte

To Acquire Forte news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 20 publisher sources 100/100 entity strength

Latest news

Argenx Announces Commencement Of Tender Offer To Acquire Forte Biosciences, Inc. >ARGX.BT - MoomooMoomoo · Fri, 07 Aug 2026 03:39:31 GMTForte Biosciences (FBRX) faces $77 per share cash tender offer from argenx - Stock TitanStock Titan · Thu, 06 Aug 2026 12:08:47 GMTargenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. - uk.finance.yahoo.comuk.finance.yahoo.com · Thu, 06 Aug 2026 11:48:00 GMTForte Biosciences (FBRX) backs $77 per share cash offer from argenx - Stock TitanStock Titan · Thu, 06 Aug 2026 11:37:10 GMTargenx to acquire Forte Biosciences (NASDAQ: FBRX) in $77 cash tender - Stock TitanStock Titan · Thu, 06 Aug 2026 11:18:43 GMTArgenx To Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, To Its Immunology Pipeline >ARGX.BT - MoomooMoomoo · Thu, 30 Jul 2026 07:00:00 GMTargenx to acquire Forte Biosciences for $2.2 billion, strengthens immunology pipeline - Indian Pharma PostIndian Pharma Post · Wed, 29 Jul 2026 06:33:48 GMTargenx to acquire Forte Biosciences (FBRX) via planned tender offer - Stock TitanStock Titan · Tue, 28 Jul 2026 22:35:56 GMT

Timeline

Fri, 07 Aug 2026 03:39:31 GMTArgenx Announces Commencement Of Tender Offer To Acquire Forte Biosciences, Inc. >ARGX.BT - Moomoo
Thu, 06 Aug 2026 12:08:47 GMTForte Biosciences (FBRX) faces $77 per share cash tender offer from argenx - Stock Titan
Thu, 06 Aug 2026 11:48:00 GMTargenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. - uk.finance.yahoo.com
Thu, 06 Aug 2026 11:37:10 GMTForte Biosciences (FBRX) backs $77 per share cash offer from argenx - Stock Titan
Thu, 06 Aug 2026 11:18:43 GMTargenx to acquire Forte Biosciences (NASDAQ: FBRX) in $77 cash tender - Stock Titan
Thu, 30 Jul 2026 07:00:00 GMTArgenx To Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, To Its Immunology Pipeline >ARGX.BT - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for To Acquire Forte.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

20 distinct publisher/source names are currently connected to this entity page.